121 related articles for article (PubMed ID: 19250823)
1. Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.
Cameron KO; Lefker BA; Ke HZ; Li M; Zawistoski MP; Tjoa CM; Wright AS; DeNinno SL; Paralkar VM; Owen TA; Yu L; Thompson DD
Bioorg Med Chem Lett; 2009 Apr; 19(7):2075-8. PubMed ID: 19250823
[TBL] [Abstract][Full Text] [Related]
2. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing.
Li M; Ke HZ; Qi H; Healy DR; Li Y; Crawford DT; Paralkar VM; Owen TA; Cameron KO; Lefker BA; Brown TA; Thompson DD
J Bone Miner Res; 2003 Nov; 18(11):2033-42. PubMed ID: 14606517
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 receptor subtype EP-2 is not involved in the induction of non-pregnant guinea pig uterine contractions associated with terminal pregnancy.
Lebel W; Riccardi K; Grasser WA; Terry K; Thompson D; Paralkar VM
Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):399-404. PubMed ID: 15519499
[TBL] [Abstract][Full Text] [Related]
4. Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats.
Cameron KO; Lefker BA; Chu-Moyer MY; Crawford DT; Jardine PD; DeNinno SL; Gilbert S; Grasser WA; Ke H; Lu B; Owen TA; Paralkar VM; Qi H; Scott DO; Thompson DD; Tjoa CM; Zawistoski MP
Bioorg Med Chem Lett; 2006 Apr; 16(7):1799-802. PubMed ID: 16442794
[TBL] [Abstract][Full Text] [Related]
5. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing.
Paralkar VM; Borovecki F; Ke HZ; Cameron KO; Lefker B; Grasser WA; Owen TA; Li M; DaSilva-Jardine P; Zhou M; Dunn RL; Dumont F; Korsmeyer R; Krasney P; Brown TA; Plowchalk D; Vukicevic S; Thompson DD
Proc Natl Acad Sci U S A; 2003 May; 100(11):6736-40. PubMed ID: 12748385
[TBL] [Abstract][Full Text] [Related]
6. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.
Johnson KA; Prakash C
Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists.
Xiao Y; Araldi GL; Zhao Z; Brugger N; Karra S; Fischer D; Palmer E
Bioorg Med Chem Lett; 2007 Aug; 17(15):4323-7. PubMed ID: 17531488
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a gamma-lactam as a highly selective EP2 and EP4 receptor agonist.
Xiao Y; Araldi GL; Zhao Z; Reddy A; Karra S; Brugger N; Fischer D; Palmer E; Bao B; McKenna SD
Bioorg Med Chem Lett; 2008 Jan; 18(2):821-4. PubMed ID: 18039575
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo.
Nomi T; Sho M; Akahori T; Kanehiro H; Nakajima Y
Transplant Proc; 2006 Dec; 38(10):3209-10. PubMed ID: 17175225
[TBL] [Abstract][Full Text] [Related]
12. The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.
Blouin M; Han Y; Burch J; Farand J; Mellon C; Gaudreault M; Wrona M; Lévesque JF; Denis D; Mathieu MC; Stocco R; Vigneault E; Therien A; Clark P; Rowland S; Xu D; O'Neill G; Ducharme Y; Friesen R
J Med Chem; 2010 Mar; 53(5):2227-38. PubMed ID: 20163116
[TBL] [Abstract][Full Text] [Related]
13. Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus.
Terry KK; Lebel WS; Riccardi KA; Grasser WA; Thompson DD; Paralkar VM
Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):3-10. PubMed ID: 18036799
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
[TBL] [Abstract][Full Text] [Related]
15. Discovery of new chemical leads for selective EP1 receptor antagonists.
Naganawa A; Saito T; Nagao Y; Egashira H; Iwahashi M; Kambe T; Koketsu M; Yamamoto H; Kobayashi M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Aug; 14(16):5562-77. PubMed ID: 16697646
[TBL] [Abstract][Full Text] [Related]
16. Lactams as EP4 prostanoid receptor agonists. 3. Discovery of N-ethylbenzoic acid 2-pyrrolidinones as subtype selective agents.
Elworthy TR; Brill ER; Chiou SS; Chu F; Harris JR; Hendricks RT; Huang J; Kim W; Lach LK; Mirzadegan T; Yee C; Walker KA
J Med Chem; 2004 Dec; 47(25):6124-7. PubMed ID: 15566283
[TBL] [Abstract][Full Text] [Related]
17. Discovery of heteroaryl sulfonamides as new EP1 receptor selective antagonists.
Naganawa A; Matsui T; Saito T; Ima M; Tatsumi T; Yamamoto S; Murota M; Yamamoto H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Oct; 14(19):6628-39. PubMed ID: 16784865
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists.
Zhao Z; Araldi GL; Xiao Y; Reddy AP; Liao Y; Karra S; Brugger N; Fischer D; Palmer E
Bioorg Med Chem Lett; 2007 Dec; 17(23):6572-5. PubMed ID: 17931866
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist.
Onishi E; Fujibayashi S; Takemoto M; Neo M; Maruyama T; Kokubo T; Nakamura T
Biomaterials; 2008 Mar; 29(7):877-83. PubMed ID: 18045684
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Disubstituted indole acylsulfonamides: a novel series of potent and selective human EP3 receptor antagonists.
Zhou N; Zeller W; Krohn M; Anderson H; Zhang J; Onua E; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
Bioorg Med Chem Lett; 2009 Jan; 19(1):123-6. PubMed ID: 19022669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
